Diagnosis of infectious diseases such as influenza is seeing a sea change owing to technological innovations and development of next-generation molecular tests such as Nuclear Acid Amplification Tests (NAATs) and advanced immunoassays. The global rapid influenza diagnostic tests market size will witness robust expansion at over 8% CAGR during the forecast period (2019 – 2029).
Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/30928
Conventional immunoassays tend to be limited by their sensitivity and specificity, a shortcoming expected to be overcome through product innovation by key molecular diagnostics companies. Quidel and BD integrated electronic readers with immunoassays, to increase test sensitivity without switching to other expensive detection devices.
Key Takeaways – Rapid Influenza Diagnostic Tests Market Study
Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/30928
Considerable impact of global public health organizations in identifying effective flu management strategies coupled with rapid uptake of point-of-care diagnostic tools by primary care physicians are further augmenting the growth prospects for rapid influenza diagnostic tests market.
Strategic Expansion Strategies of Leading Players Shaping Market
Prominent molecular diagnostics vendors are focusing on establishing long-term supply relationships with diagnostic centers and other testing facilities. They are emphasizing more on increasing their sales force and entering into strategic partnerships with local suppliers and distributors to expand product reach.
For instance, Cardinal Health collaborated with Qiagen to distribute the company’s molecular diagnostic products to smaller and mid-sized U.S. hospitals.
According to the American Hospital Association, there are around 5,000 community hospitals in the U.S., and this share is anticipated to grow exponentially due to substantial growth projections for players in the rapid influenza diagnostic tests market.
Moreover, the rapid influenza diagnostic tests market is expected to witness significant growth, which is attributed to a robust pipeline of innovative products.
Access Full Report @ https://www.persistencemarketresearch.com/checkout/30928
Know More About the Report
Persistence Market Research offers a unique perspective and actionable insights on rapid influenza diagnostic tests in its latest study, presenting historical demand assessment from 2014 – 2018 and projections from 2019 – 2029 on the basis of principle (immunochromatographic assays, immunofluorescence assays and nucleic acid amplification test (NAAT)), type (influenza A test, influenza B test and influenza A+B test), sample type (throat swab, nasal swab, nasal aspirate, nasal wash, nasopharyngeal swab, nasopharyngeal aspirate, nasopharyngeal wash and others) and end user (hospitals, diagnostic centers, nursing homes, office-based settings, urgent care centers, retail pharmacy clinics, schools & universities, public health camps and others (cruise ships, correctional facilities, etc.) in seven prominent regions.
Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape
Intravenous Iron Drugs Market –
Intravenous (IV) Iron Drugs Market Segmentation by Key Players- Actavis, Inc., AMAG Pharmaceuticals, Inc., Galenica Ltd., Fresenius Medical Care AG & Co. KGaA, Vifor Pharma Ltd., American Regent, Inc., Luitpold Pharmaceuticals, Inc., Pharmacosmos A/S, Rockwell Medical Technologies, Inc., and Sanofi.
Syndromes Progressive Ataxia Weakness Disorders Market –
Treatments for Syndromes of Progressive Ataxia and Weakness Disorders Market Segmentation by Key Players- Abbott Laboratories, Acorda Therapeutics Inc., American Regent Inc., Baxter International Inc., Biogen Idec., Bristol-Myers Squibb, Cadila Healthcare Ltd., Eli Lilly and Company, Glaxosmilthkline Plc., Sanofi, Roche Holding Ltd., Pfizer Inc. and Novartis AG.
Persistence Market Research
305 Broadway,7th Floor
New York City, NY 10007
U.S. Phone - +1-646-568-7751
U.S.-Canada Toll-free : +1 800-961-0353
E-mail id - email@example.com
Website : www.persistencemarketresearch.com